| Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association MJ Feinstein, PY Hsue, LA Benjamin, GS Bloomfield, JS Currier, ... Circulation 140 (2), e98-e124, 2019 | 485 | 2019 |
| Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013 MJ Feinstein, E Bahiru, C Achenbach, CT Longenecker, P Hsue, ... The American journal of cardiology 117 (2), 214-220, 2016 | 295 | 2016 |
| Disparities in cardiovascular mortality related to heart failure in the United States P Glynn, DM Lloyd-Jones, MJ Feinstein, M Carnethon, SS Khan Journal of the American College of Cardiology 73 (18), 2354-2355, 2019 | 190 | 2019 |
| HIV and cardiovascular disease K So-Armah, LA Benjamin, GS Bloomfield, MJ Feinstein, P Hsue, ... The lancet HIV 7 (4), e279-e293, 2020 | 179 | 2020 |
| Assessing and refining myocardial infarction risk estimation among patients with human immunodeficiency virus: a study by the Centers for AIDS Research Network of Integrated … MJ Feinstein, RM Nance, DR Drozd, H Ning, JA Delaney, SR Heckbert, ... JAMA cardiology 2 (2), 155-162, 2017 | 103 | 2017 |
| Burden of cardiovascular risk factors, subclinical atherosclerosis, and incident cardiovascular events across dimensions of religiosity: The multi-ethnic study of atherosclerosis M Feinstein, K Liu, H Ning, G Fitchett, DM Lloyd-Jones Circulation 121 (5), 659-666, 2010 | 99 | 2010 |
| Racial differences in risks for first cardiovascular events and noncardiovascular death: the Atherosclerosis Risk in Communities study, the Cardiovascular Health Study, and the … M Feinstein, H Ning, J Kang, A Bertoni, M Carnethon, DM Lloyd-Jones Circulation 126 (1), 50-59, 2012 | 96 | 2012 |
| A systematic review of the usefulness of statin therapy in HIV-infected patients MJ Feinstein, CJ Achenbach, NJ Stone, DM Lloyd-Jones The American journal of cardiology 115 (12), 1760-1766, 2015 | 92 | 2015 |
| Adjudicated heart failure in HIV‐infected and uninfected men and women MJ Feinstein, AB Steverson, H Ning, AE Pawlowski, D Schneider, ... Journal of the American Heart Association 7 (21), e009985, 2018 | 82 | 2018 |
| Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy V Rajaram, S Pandhya, S Patel, PM Meyer, M Goldin, MJM Feinstein, ... The American journal of cardiology 93 (11), 32-48, 2004 | 78 | 2004 |
| Types of myocardial infarction among human immunodeficiency virus–infected individuals in the United States HM Crane, P Paramsothy, DR Drozd, RM Nance, JAC Delaney, ... JAMA cardiology 2 (3), 260-267, 2017 | 74 | 2017 |
| Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual‐level reanalysis of CORONA and GISSI‐HF MJ Feinstein, P Jhund, J Kang, H Ning, A Maggioni, J Wikstrand, ... European Journal of Heart Failure 17 (4), 434-441, 2015 | 58 | 2015 |
| Differential associations of chronic inflammatory diseases with incident heart failure S Prasada, A Rivera, A Nishtala, AE Pawlowski, A Sinha, JD Bundy, ... Heart Failure 8 (6), 489-498, 2020 | 48 | 2020 |
| Cardiovascular complications of HIV in endemic countries MJ Feinstein, M Bogorodskaya, GS Bloomfield, R Vedanthan, MJ Siedner, ... Current cardiology reports 18, 1-12, 2016 | 42 | 2016 |
| Ideal cardiovascular health and carotid atherosclerosis in a mixed cohort of HIV-infected and uninfected Ugandans MJ Feinstein, JH Kim, P Bibangambah, R Sentongo, JN Martin, AC Tsai, ... AIDS research and human retroviruses 33 (1), 49-56, 2017 | 41 | 2017 |
| Coronary artery disease manifestations in HIV: what, how, and why A Sinha, MJ Feinstein Canadian Journal of Cardiology 35 (3), 270-279, 2019 | 40 | 2019 |
| Incident obesity and cardiovascular risk factors between young adulthood and middle age by religious involvement: The Coronary Artery Risk Development in Young Adults (CARDIA … M Feinstein, K Liu, H Ning, G Fitchett, DM Lloyd-Jones Preventive medicine 54 (2), 117-121, 2012 | 39 | 2012 |
| Atrial arrhythmia prevalence and characteristics for human immunodeficiency virus-infected persons and matched uninfected controls JM Sanders, AB Steverson, AE Pawlowski, D Schneider, CJ Achenbach, ... PLoS One 13 (3), e0194754, 2018 | 34 | 2018 |
| Emerging, noninvasive surrogate markers of atherosclerosis SN Patel, V Rajaram, S Pandya, BM Fiedler, CJ Bai, R Neems, ... Current atherosclerosis reports 6, 60-68, 2004 | 33 | 2004 |
| Epidemiology, pathophysiology, and prevention of heart failure in people with HIV A Sinha, M Feinstein Progress in cardiovascular diseases 63 (2), 134-141, 2020 | 32 | 2020 |
